BENEVICH ERIC bought NBIX
March 14, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 69,521 shares of Neurocrine Biosciences, Inc. at $81.05 per share, a transaction worth $5.63M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
69,521
Price
$81.05
Total value
$5.63M
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 14, 2024
Filing dateMarch 15, 2024
Shares owned after110,299
OwnershipDirect
10b5-1 planNo
AmendedNo